Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus.
Ontology highlight
ABSTRACT: Hepatitis C virus (HCV) presents a significant global health issue due to its widespread prevalence and the absence of a reliable vaccine for prevention. While significant progress has been achieved in therapeutic interventions since the disease was first identified, its resurgence underscores the need for innovative strategies to combat it. The nonstructural protein NS5A is crucial in the life cycle of the HCV, serving as a significant factor in both viral replication and assembly processes. This significance is highlighted by its inclusion in all existing approved HCV combination therapies. In this study, a quantitative structure-activity relationship (QSAR) was conducted to design new compounds with enhanced inhibitory activity against HCV. In this context, a set of 82 phenylthiazole de
SUBMITTER: Liman W
PROVIDER: S-EPMC11686136 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA